History of Innovation
FDA clears the first nucleic acid test.
FDA clears the first nucleic acid test.
AEµç×Ó introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis.
AEµç×Ó introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis.
FDA clears the first molecular diagnostic test kit for a sexually transmitted infection.
FDA clears the first molecular diagnostic test kit for a sexually transmitted infection.
FDA approves the Rapid fFN® test.
FDA approves the Rapid fFN® test.
FDA approves the °Õ³ó¾±²Ô±Ê°ù±ð±è® Pap test, liquid-based cytology for cervical cancer screening.
FDA approves the °Õ³ó¾±²Ô±Ê°ù±ð±è® Pap test, liquid-based cytology for cervical cancer screening.
FDA approves the ±·´Ç±¹²¹³§³Ü°ù±ð® endometrial ablation treatment for abnormal uterine bleeding (AUB).
FDA approves the ±·´Ç±¹²¹³§³Ü°ù±ð® endometrial ablation treatment for abnormal uterine bleeding (AUB).
FDA approves the ³§±ð±ô±ð²Ô¾±²¹Â® mammography system–the beginning of a new era in breast cancer screening.
FDA approves the ³§±ð±ô±ð²Ô¾±²¹Â® mammography system–the beginning of a new era in breast cancer screening.
FDA approves the first nucleic acid test for screening donated blood prior to transfusion.
*Procleix and Ultrio are registered trademarks of Grifols, SA.
FDA approves the first nucleic acid test for screening donated blood prior to transfusion.
*Procleix and Ultrio are registered trademarks of Grifols, SA.
Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs).
Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs).
FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C.
*Procleix and Ultrio are registered trademarks of Grifols, SA.
FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C.
*Procleix and Ultrio are registered trademarks of Grifols, SA.
FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the AEµç×Ó 3D Mammographyâ„¢ exam.
FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the AEµç×Ó 3D Mammographyâ„¢ exam.
FDA clears the ±Ê²¹²Ô³Ù³ó±ð°ù® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay.
FDA clears the ±Ê²¹²Ô³Ù³ó±ð°ù® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay.
FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis
FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis